Esch Kevin 4

What Happened
Kevin Esch, Executive Vice President of Zoetis (ZTS), received shares as restricted stock units (RSUs) vested on Feb 6 and Feb 8, 2026. The filing reports acquisition of 43 shares (2/6) and 50 shares (2/8) upon RSU settlement (total 93 shares). To satisfy tax withholding obligations, 15 shares (2/6) and 18 shares (2/8) were withheld/disposed at $127.42 per share, totaling $1,911 and $2,294 respectively (combined $4,205). Net shares retained from these events = 93 − 33 = 60 shares.

Key Details

• Transaction dates: Feb 6, 2026 and Feb 8, 2026; Form 4 filed Feb 10, 2026 (appears timely).
• Acquisitions: 43 shares (2/6) and 50 shares (2/8) via RSU settlement (transaction code M = conversion of derivative).
• Withholding/disposals: 15 shares (2/6) and 18 shares (2/8) to cover taxes (transaction code F); price used = $127.42/share; total withholding = $4,205.
• Net shares added to Esch’s holdings from these vestings: 60 shares.
• Footnotes indicate these were RSUs granted under Zoetis’ equity plans (each RSU = right to one share) and subject to vesting schedules (see F1–F9).
• The filing includes fractional RSU conversion amounts (e.g., 43.257, 50.731) reported for accounting of the derivative conversions.

Context

• These transactions are not open-market buys or discretionary sales but routine RSU vesting and net settlement for tax withholding (a common practice).
• Transaction codes: M = exercise/conversion of a derivative (here, RSU settlement); F = payment of exercise price or tax liability (shares withheld).
• Such award vestings reflect compensation settling into stock and do not, by themselves, signal insider buying intent.